论文部分内容阅读
Lyrica CR缓释片规格有82.5 mg、165 mg和330 mg。用药方面:Lyrica CR缓释片每天服药1次,晚饭后服用,该药需吞服,不可分割、压碎或咀嚼。治疗pDPN疼痛时,起始剂量为每天165 mg,1周内最大剂量为每天330 mg;治疗PHN时,起始剂量为每天165 mg,1周内最大剂量为每天330 mg,最大给药剂量为每天660 mg。Lyrica是全球最畅销的镇痛药,已上市剂型包括胶囊和口服溶液,每天服用2~3次。目前,Lyrica已被批准用于治疗与糖尿病周围神经病变神经痛、带状疱疹后神经痛、脊髓损伤相关神经
Lyrica CR sustained release tablets are available in 82.5 mg, 165 mg and 330 mg. Medication: Lyrica CR sustained-release tablets once a day, taken after dinner, the drug swallowed, indivisible, crushed or chewed. The initial dose for pDPN pain was 165 mg daily, with a maximum daily dose of 330 mg for 1 week, and a starting dose of 165 mg daily for PHN. The maximum daily dose was 330 mg for 1 week, and the maximum dose was 660 mg daily. Lyrica is the best-selling analgesic in the world, and marketed formulations include capsules and oral solutions taken 2 to 3 times a day. Currently, Lyrica has been approved for the treatment of neuropathies associated with diabetic peripheral neuropathy, post-herpetic neuralgia, spinal cord injury-related nerves